High-dose convalescent plasma for treatment of severe COVID-19 (2022)
Source: Emerging Infectious Diseases. Unidade: FMRP
Subjects: COVID-19, IMUNIZAÇÃO PASSIVA, PLASMA, RESULTADO DE TRATAMENTO
ABNT
DE SANTIS, Gil Cunha et al. High-dose convalescent plasma for treatment of severe COVID-19. Emerging Infectious Diseases, v. 28, n. 3, p. 548-555, 2022Tradução . . Disponível em: https://doi.org/10.3201/eid2803.212299. Acesso em: 02 nov. 2024.APA
De Santis, G. C., Oliveira, L. C., Garibaldi, P. M. M., Almado, C. E. L., Croda, J., Arcanjo, G. G. A., et al. (2022). High-dose convalescent plasma for treatment of severe COVID-19. Emerging Infectious Diseases, 28( 3), 548-555. doi:10.3201/eid2803.212299NLM
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi Júnior DM, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA, Pontelli MC, Gomes R, Miranda CH, Martins MA, Covas DT, Arruda E, Fonseca BAL da, Calado RT. High-dose convalescent plasma for treatment of severe COVID-19 [Internet]. Emerging Infectious Diseases. 2022 ; 28( 3): 548-555.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3201/eid2803.212299Vancouver
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi Júnior DM, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA, Pontelli MC, Gomes R, Miranda CH, Martins MA, Covas DT, Arruda E, Fonseca BAL da, Calado RT. High-dose convalescent plasma for treatment of severe COVID-19 [Internet]. Emerging Infectious Diseases. 2022 ; 28( 3): 548-555.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3201/eid2803.212299